Shares of IOL Chemicals and Pharmaceuticals Ltd on Tuesday, November 11, reported a 56.3% year-on-year (YoY) growth in net profit to ₹30 crore for the second quarter that ended September 30, 2025. Net profit for the same quarter last year stood at ₹19.2 crore.

It reported ₹567.5 crore in revenue from operations, up 8% YoY and 2.8% sequentially. Revenue in the same quarter last year stood at ₹525.8 crore while in the June quarter IOL reported a revenue of ₹552 crore.

Earnings before interest, tax, depreciation and amortisation (EBITDA) grew by 37% from last year to ₹57 crore, while EBITDA margin improved by 210 basis points to 10% from 7.9% a year earlier.

In October, IOL Chemicals and Pharmaceuticals informed the exchanges that it had incorporated a wholly-owned subsidiary, IOL Phar

See Full Page